Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2010 1
2011 2
2012 2
2013 5
2014 2
2015 3
2016 3
2017 1
2019 1
2020 2
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Special locations dermoscopy: facial, acral, and nail.
Thomas L, Phan A, Pralong P, Poulalhon N, Debarbieux S, Dalle S. Thomas L, et al. Among authors: poulalhon n. Dermatol Clin. 2013 Oct;31(4):615-24, ix. doi: 10.1016/j.det.2013.06.006. Epub 2013 Aug 23. Dermatol Clin. 2013. PMID: 24075549 Review.
Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.
Pham F, Boespflug A, Duru G, Phan A, Poulalhon N, Weiler L, Tanaka M, Lallas A, Ogata D, Davaine AC, Bahadoran P, Balguerie X, Kamińska-Winciorek G, Tromme I, Correia O, Kim MB, Marghoob AA, Linda Martin, Guitera P, Meziane M, Miquel J, Mun JH, Argenziano G, Bessis D, Bourke J, Mijuskovic Z, Chiaverini C, Corven-Benoit C, Droitcourt C, Skowron F, Marque M, Zalaudek I, Rosendahl C, Moreno-Ramirez D, Vabres P, Haenssle H, Malvehy J, Puig S, Robert C, Schopf TR, Scope A, Dalle S, Thomas L. Pham F, et al. Among authors: poulalhon n. J Am Acad Dermatol. 2022 Sep;87(3):551-558. doi: 10.1016/j.jaad.2022.01.028. Epub 2022 Jan 29. J Am Acad Dermatol. 2022. PMID: 35104588 Free PMC article.
Vismodegib efficacy in unresectable trichoblastic carcinoma: A multicenter study of 16 cases.
Duplaine A, Beylot-Barry M, Mansard S, Arnault JP, Grob JJ, Maillard H, Saiag P, Poulalhon N, Cribier B, Mortier L, Battistella M, Jouary T. Duplaine A, et al. Among authors: poulalhon n. J Am Acad Dermatol. 2022 Jun;86(6):1365-1366. doi: 10.1016/j.jaad.2021.05.024. Epub 2021 May 27. J Am Acad Dermatol. 2022. PMID: 34052337 No abstract available.
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma.
Yurchenko AA, Pop OT, Ighilahriz M, Padioleau I, Rajabi F, Sharpe HJ, Poulalhon N, Dreno B, Khammari A, Delord M, Alberti A, Soufir N, Battistella M, Mourah S, Bouquet F, Savina A, Besse A, Mendez-Lopez M, Grange F, Monestier S, Mortier L, Meyer N, Dutriaux C, Robert C, Saiag P, Herms F, Lambert J, de Sauvage FJ, Dumaz N, Flatz L, Basset-Seguin N, Nikolaev SI. Yurchenko AA, et al. Among authors: poulalhon n. Clin Cancer Res. 2022 Apr 1;28(7):1422-1432. doi: 10.1158/1078-0432.CCR-21-3764. Clin Cancer Res. 2022. PMID: 35078858 Free PMC article.
Vemurafenib in melanoma with BRAF V600E mutation.
Dalle S, Poulalhon N, Thomas L. Dalle S, et al. Among authors: poulalhon n. N Engl J Med. 2011 Oct 13;365(15):1448-9; author reply 1450. doi: 10.1056/NEJMc1108651. N Engl J Med. 2011. PMID: 21995399 No abstract available.
Tracking of second primary melanomas in vemurafenib-treated patients.
Dalle S, Poulalhon N, Debarbieux S, Zaharia D, Mihm MC, Lacouture ME, Rosen A, Marghoob AA, Busam KJ, Depaepe L, Bringuier PP, Richez P, Baurain JF, Bressac-de Paillerets B, Balme B, Thomas L. Dalle S, et al. Among authors: poulalhon n. JAMA Dermatol. 2013 Apr;149(4):488-90. doi: 10.1001/jamadermatol.2013.21. JAMA Dermatol. 2013. PMID: 23715012 No abstract available.
27 results